United States 3D Printed Drugs Market Report & Forecast 2021-2027

Publisher Name :
Date: 24-Nov-2021
No. of pages: 94
Inquire Before Buying

United States 3D Printed Drugs Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K Units)

United States 3D Printed Drugs Market Segment Percentages, By Type, 2020 (%)

- Spritam

- Others

United States 3D Printed Drugs Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K Units)

United States 3D Printed Drugs Market Segment Percentages, By Application, 2020 (%)

- Children

- Elderly

- Others

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies 3D Printed Drugs revenues in United States market, 2016-2021 (Estimated), ($ millions)

Key companies 3D Printed Drugs revenues share in United States market, 2020 (%)

Key companies 3D Printed Drugs sales in United States market, 2016-2021 (Estimated), (K Units)

Key companies 3D Printed Drugs sales share in United States market, 2020 (%)

Further, the report presents profiles of competitors in the market, key players include:

- Aprecia Pharmaceuticals

- GlaxoSmithKline

- Revolution Medicines

- FabRX

United States 3D Printed Drugs Market Report & Forecast 2021-2027

Table of Contents
1 Introduction to Research & Analysis Reports
1.1 3D Printed Drugs Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 United States 3D Printed Drugs Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 United States 3D Printed Drugs Overall Market Size
2.1 United States 3D Printed Drugs Market Size: 2021 VS 2027
2.2 United States 3D Printed Drugs Revenue, Prospects & Forecasts: 2016-2027
2.3 United States 3D Printed Drugs Sales: 2016-2027
3 Company Landscape
3.1 Top 3D Printed Drugs Players in United States Market
3.2 Top United States 3D Printed Drugs Companies Ranked by Revenue
3.3 United States 3D Printed Drugs Revenue by Companies
3.4 United States 3D Printed Drugs Sales by Companies
3.5 United States 3D Printed Drugs Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 3D Printed Drugs Companies in United States Market, by Revenue in 2020
3.7 Manufacturers 3D Printed Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 3D Printed Drugs Players in United States Market
3.8.1 List of Tier 1 3D Printed Drugs Companies in United States
3.8.2 List of Tier 2 and Tier 3 3D Printed Drugs Companies in United States
4 Sights by Type
4.1 Overview
4.1.1 By Type - United States 3D Printed Drugs Market Size Markets, 2021 & 2027
4.1.2 Spritam
4.1.3 Others
4.2 By Type - United States 3D Printed Drugs Revenue & Forecasts
4.2.1 By Type - United States 3D Printed Drugs Revenue, 2016-2021
4.2.2 By Type - United States 3D Printed Drugs Revenue, 2022-2027
4.2.3 By Type - United States 3D Printed Drugs Revenue Market Share, 2016-2027
4.3 By Type - United States 3D Printed Drugs Sales & Forecasts
4.3.1 By Type - United States 3D Printed Drugs Sales, 2016-2021
4.3.2 By Type - United States 3D Printed Drugs Sales, 2022-2027
4.3.3 By Type - United States 3D Printed Drugs Sales Market Share, 2016-2027
4.4 By Type - United States 3D Printed Drugs Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - United States 3D Printed Drugs Market Size, 2021 & 2027
5.1.2 Children
5.1.3 Elderly
5.1.4 Others
5.2 By Application - United States 3D Printed Drugs Revenue & Forecasts
5.2.1 By Application - United States 3D Printed Drugs Revenue, 2016-2021
5.2.2 By Application - United States 3D Printed Drugs Revenue, 2022-2027
5.2.3 By Application - United States 3D Printed Drugs Revenue Market Share, 2016-2027
5.3 By Application - United States 3D Printed Drugs Sales & Forecasts
5.3.1 By Application - United States 3D Printed Drugs Sales, 2016-2021
5.3.2 By Application - United States 3D Printed Drugs Sales, 2022-2027
5.3.3 By Application - United States 3D Printed Drugs Sales Market Share, 2016-2027
5.4 By Application - United States 3D Printed Drugs Price (Manufacturers Selling Prices), 2016-2027
6 Manufacturers & Brands Profiles
6.1 Aprecia Pharmaceuticals
6.1.1 Aprecia Pharmaceuticals Corporation Information
6.1.2 Aprecia Pharmaceuticals Overview
6.1.3 Aprecia Pharmaceuticals 3D Printed Drugs Sales and Revenue in United States Market (2016-2021)
6.1.4 Aprecia Pharmaceuticals 3D Printed Drugs Product Description
6.1.5 Aprecia Pharmaceuticals Recent Developments
6.2 GlaxoSmithKline
6.2.1 GlaxoSmithKline Corporation Information
6.2.2 GlaxoSmithKline Overview
6.2.3 GlaxoSmithKline 3D Printed Drugs Sales and Revenue in United States Market (2016-2021)
6.2.4 GlaxoSmithKline 3D Printed Drugs Product Description
6.2.5 GlaxoSmithKline Recent Developments
6.3 Revolution Medicines
6.3.1 Revolution Medicines Corporation Information
6.3.2 Revolution Medicines Overview
6.3.3 Revolution Medicines 3D Printed Drugs Sales and Revenue in United States Market (2016-2021)
6.3.4 Revolution Medicines 3D Printed Drugs Product Description
6.3.5 Revolution Medicines Recent Developments
6.4 FabRX
6.4.1 FabRX Corporation Information
6.4.2 FabRX Overview
6.4.3 FabRX 3D Printed Drugs Sales and Revenue in United States Market (2016-2021)
6.4.4 FabRX 3D Printed Drugs Product Description
6.4.5 FabRX Recent Developments
7 United States 3D Printed Drugs Production Capacity, Analysis
7.1 United States 3D Printed Drugs Production Capacity, 2016-2027
7.2 3D Printed Drugs Production Capacity of Key Manufacturers in United States Market
8 Key Market Trends, Opportunity, Drivers and Restraints
8.1 Market Opportunities & Trends
8.2 Market Drivers
8.3 Market Restraints
9 3D Printed Drugs Supply Chain Analysis
9.1 3D Printed Drugs Industry Value Chain
9.2 3D Printed Drugs Upstream Market
9.3 3D Printed Drugs Downstream and Clients
9.4 Marketing Channels Analysis
9.4.1 Marketing Channels
9.4.2 3D Printed Drugs Distributors and Sales Agents in United States Market
10 Conclusion
11 Appendix
11.1 Note
11.2 Examples of Clients
11.3 Author Details
11.4 Disclaimer
List of Tables
Table 1. Key Players of 3D Printed Drugs in United States Market
Table 2. Top 3D Printed Drugs Players in United States Market, Ranking by Revenue (2019)
Table 3. United States 3D Printed Drugs Revenue by Companies, (US$, Mn), 2016-2021
Table 4. United States 3D Printed Drugs Revenue Share by Companies, 2016-2021
Table 5. United States 3D Printed Drugs Sales by Companies, (K Units), 2016-2021
Table 6. United States 3D Printed Drugs Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers 3D Printed Drugs Price (2016-2021) & (USD/Unit)
Table 8. Manufacturers 3D Printed Drugs Product Type
Table 9. List of Tier 1 3D Printed Drugs Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 3D Printed Drugs Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. Major Manufacturers of Spritam
Table 12. Major Manufacturers of Others
Table 13. By Type - United States 3D Printed Drugs Revenue, (US$, Mn), 2021 & 2027
Table 14. By Type - United States 3D Printed Drugs Revenue (US$, Mn), 2016-2021
Table 15. By Type - United States 3D Printed Drugs Revenue (US$, Mn), 2022-2027
Table 16. By Type - United States 3D Printed Drugs Sales (K Units), 2016-2021
Table 17. By Type - United States 3D Printed Drugs Sales (K Units), 2022-2027
Table 18. By Application - United States 3D Printed Drugs Revenue, (US$, Mn), 2021 VS 2027
Table 19. By Application - United States 3D Printed Drugs Revenue (US$, Mn), 2016-2021
Table 20. By Application - United States 3D Printed Drugs Revenue (US$, Mn), 2022-2027
Table 21. By Application - United States 3D Printed Drugs Sales (K Units), 2016-2021
Table 22. By Application - United States 3D Printed Drugs Sales (K Units), 2022-2027
Table 23. Aprecia Pharmaceuticals Corporation Information
Table 24. Aprecia Pharmaceuticals Description and Major Businesses
Table 25. Aprecia Pharmaceuticals 3D Printed Drugs Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 26. Aprecia Pharmaceuticals 3D Printed Drugs Product
Table 27. Aprecia Pharmaceuticals Recent Developments
Table 28. GlaxoSmithKline Corporation Information
Table 29. GlaxoSmithKline Description and Major Businesses
Table 30. GlaxoSmithKline 3D Printed Drugs Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 31. GlaxoSmithKline 3D Printed Drugs Product
Table 32. GlaxoSmithKline Recent Developments
Table 33. Revolution Medicines Corporation Information
Table 34. Revolution Medicines Description and Major Businesses
Table 35. Revolution Medicines 3D Printed Drugs Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 36. Revolution Medicines 3D Printed Drugs Product
Table 37. Revolution Medicines Recent Developments
Table 38. FabRX Corporation Information
Table 39. FabRX Description and Major Businesses
Table 40. FabRX 3D Printed Drugs Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 41. FabRX 3D Printed Drugs Product
Table 42. FabRX Recent Developments
Table 43. 3D Printed Drugs Production Capacity (K Units) of Key Manufacturers in United States Market, 2019-2021 (K Units)
Table 44. United States 3D Printed Drugs Capacity Market Share of Key Manufacturers, 2019-2021
Table 45. 3D Printed Drugs Market Opportunities & Trends in United States Market
Table 46. 3D Printed Drugs Market Drivers in United States Market
Table 47. 3D Printed Drugs Market Restraints in United States Market
Table 48. 3D Printed Drugs Raw Materials
Table 49. 3D Printed Drugs Raw Materials Suppliers in United States Market
Table 50. Typical 3D Printed Drugs Downstream
Table 51. 3D Printed Drugs Downstream Clients in United States Market
Table 52. 3D Printed Drugs Distributors and Sales Agents in United States Market
List of Figures
Figure 1. 3D Printed Drugs Product Picture
Figure 2. 3D Printed Drugs Segment by Type
Figure 3. 3D Printed Drugs Segment by Application
Figure 4. United States 3D Printed Drugs Market Overview: 2020
Figure 5. United States 3D Printed Drugs Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. United States 3D Printed Drugs Revenue, 2016-2027 (US$, Mn)
Figure 7. 3D Printed Drugs Sales in United States Market: 2016-2027 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by 3D Printed Drugs Revenue in 2020
Figure 9. Spritam Product Picture
Figure 10. Others Product Picture
Figure 11. By Type - United States 3D Printed Drugs Sales Market Share, 2016-2027
Figure 12. By Type - United States 3D Printed Drugs Revenue Market Share, 2016-2027
Figure 13. By Type - United States 3D Printed Drugs Price (USD/Unit), 2016-2027
Figure 14. Children
Figure 15. Elderly
Figure 16. Others
Figure 17. By Application - United States 3D Printed Drugs Sales Market Share, 2016-2027
Figure 18. By Application - United States 3D Printed Drugs Revenue Market Share, 2016-2027
Figure 19. By Application - United States 3D Printed Drugs Price (USD/Unit), 2016-2027
Figure 20. Aprecia Pharmaceuticals 3D Printed Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 21. GlaxoSmithKline 3D Printed Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 22. Revolution Medicines 3D Printed Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 23. FabRX 3D Printed Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 24. United States 3D Printed Drugs Production Capacity (K Units), 2016-2027
Figure 25. 3D Printed Drugs Industry Value Chain
Figure 26. Marketing Channels
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs